Biogen highlights results from late-stage natalizumab multiple sclerosis study
August 02 2021 - 7:49AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Sep 2023 to Sep 2024